drugset / Trial / NCT00212810

Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.

NCT00212810

Phase 4 Completed 385 enrolled Ortho-McNeil Neurologics, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether Topiramate is effective in preventing the development of chronic daily headache among patients with episodic migraine headaches.

Timeline

Start
2005-09
Primary completion
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 75 mg
Subject Topiramate Small molecule 100 mg